11.6% showed reistance to lomefloxacin, pefloxacin, and ofloxacin, respectively. Among the O1 and O139 serogroups isolated in 1996, a contrasting pattern of resistance to different antibiotics was observed, with the most common (71%) drug resistance in V. cholerae O1 strains being to ampicillin, chloramphenicol, co-trimoxazole, furazolidone, neomycin, nalidixic acid, and streptomycin, while the most common (66%) resistance pattern in V. cholerae O139 was ampicillin, furazolidone, neomycin, and streptomycin.
In this study, the agar dilution breakpoints adopted by the Centers for Disease Control and Prevention, Atlanta, Ga. (MICs of Ն1.0 g of ciprofloxacin and norfloxacin per ml), were used for interpretation of resistance to these agents (4). Among the fluoroquinolones, MICs of the widely used norfloxacin and ciprofloxacin for the resistant strains of V. cholerae non-O1 non-O139 ranged from 3.125 to Ͼ100 and 3.125 to 75 g/ml, respectively; MICs of norfloxacin were Ͼ100 g/ml for 5 strains, and the MIC of ciprofloxacin was about 50 g/ml.
MICs for the susceptible strains of V. cholerae non-O1 non-O139 ranged from Յ0.0245 to 0.39 g/ml for ciprofloxacin and 0.049 to 0.78 g/ml for norfloxacin. A trend of increasing MICs for susceptible strains isolated after June 1996 was observed. All strains, with the exception of one in each case, were concurrently resistant to both norfloxacin and ciprofloxacin. The emergence of fluoroquinolone-resistant V. cholerae is ominous and may be a prelude to other pathogenic Vibro species acquiring resistance, which will create major problems in treating severe cases of diarrhea when an antibiotic intervention is deemed necessary. a Antibiotic susceptibility was performed by the dry disk diffusion technique (1) with commercial discs, and strains were characterized as resistant as described in the text.
